Skip to content

A clinical study for assessing the effect of nagara taila matrabasthi in lowback ache

A Comprehensive Clinical Study On Action Of Matrabasthi With Nagara Taila In Katigraha - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089885
Enrollment
30
Registered
2025-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue Health Condition 2: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Sponsors

DR P M MANTHAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between age group of 20 to 70 years irrespective of gender. Patients with classical Lakshanas of Katigraha mentioned in Ayurveda classics. Patients with Nirama Vata Lakshana according to Ayurveda

Exclusion criteria

Exclusion criteria: Patient below 20 years and above 70 years of age. Patient suffering from other systemic disorders which interferes with the treatment. Patient with Ama condition according to Ayurveda classics.

Design outcomes

Primary

MeasureTime frame
To know the comprehensive action of Matrabasti with Nagara Taila in Nirama Katigraha with respect to chronicity. To know the comprehensive action of Matrabasti with Nagara Taila in Nirama Katigraha with respect to severity. To understand the comprehensive action of Matrabasti with Nagara Taila with respect to causative factors for the disease (with or without injury and with or without Vibanda)Timepoint: 1 TO 7 DAYS 7 TO 21 DAYS

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDR KRISHNAPRAKASH M K

KVG AYURVEDA MEDICAL COLLEGE AND HOSPITAL

drkrishnaprakashmk@gmail.com9482375338

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026